Interferon-β gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway. - Wikidata - wikimedia - TriplyDB

Interferon-β gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway.

Interferon-β gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway.

http://www.wikidata.org/entity/Q37185756

about

Genetically modified mesenchymal stromal cells in cancer therapy The Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with Inflammation High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma Paracrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R/PI3K/Akt signaling Bone marrow mesenchymal stem cells suppress metastatic tumor development in mouse by modulating immune system Primary ovarian cancer cell inhibition by human Wharton's Jelly stem cells (hWJSCs): Mapping probable mechanisms and targets using systems oncology Clinicopathological role of miR-30a-5p in hepatocellular carcinoma tissues and prediction of its function with bioinformatics analysis.Opposite Effects of Coinjection and Distant Injection of Mesenchymal Stem Cells on Breast Tumor Cell Growth.Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK/p53/miR-23a/FOXA1 pathway.Essential role of HCMV deubiquitinase in promoting oncogenesis by targeting anti-viral innate immune signaling pathways.Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse.Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype.Inhibitory effects of interferon-β on hepatocellular carcinoma HepG2 via Akt/STAT phosphorylation.

P2860

Q28071840-A46176B8-B59D-4A93-8343-843FBE02635A Q28073691-580F53B7-12BF-4FB0-A276-96162278C434 Q34340901-BDA498FB-2D14-420D-8B15-1281E93792E4 Q35399206-9581D6B3-AC31-4469-8AD6-0AF2D28C47CD Q35588431-DE0B994A-4287-429C-8902-78C104C73C34 Q36432206-CC02C900-F8CE-40C9-A4B3-52447B662F27 Q37187684-F703AE00-0D66-4BB6-A39A-1053FB32395E Q38761193-4FD86F92-6AED-4E93-93E7-B08EE61428F8 Q40641258-036973C6-C047-43F1-AD5A-F3A100E35843 Q41923781-354F1CF5-5E86-4DB3-A8AD-A9A3A5823B31 Q42391294-DB8C057B-80DA-4004-AAAB-05735FA670A9 Q42654111-976265BA-3BAD-4001-852B-CFC5F25BEC36 Q55065274-8D8FFE4B-60C8-4E98-B03E-5E1F40C56435

P2860

Interferon-β gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway.

http://www.wikidata.org/entity/Q37185756

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Interferon-β gene-modified hum ...... inhibiting AKT/FOXO3a pathway.

@en

Interferon-β gene-modified hum ...... inhibiting AKT/FOXO3a pathway.

@nl

type

label

Interferon-β gene-modified hum ...... inhibiting AKT/FOXO3a pathway.

@en

Interferon-β gene-modified hum ...... inhibiting AKT/FOXO3a pathway.

@nl

prefLabel

Interferon-β gene-modified hum ...... inhibiting AKT/FOXO3a pathway.

@en

Interferon-β gene-modified hum ...... inhibiting AKT/FOXO3a pathway.

@nl

P1433

Q37185756-0FDA39D3-78B0-423E-B733-950FAAF56A58

P1476

Q37185756-082B2400-8E25-42C5-9A5A-57DC496778BD

P2093

Q37185756-12D0A8D4-B10C-4F59-8717-CD9B75866DE5

Q37185756-18C8EDA5-9B4F-4C68-A944-F593B828E278

Q37185756-5048EFE9-52AA-4AF0-B669-7D5886E5B248

Q37185756-5AE8835C-4F9B-45FB-9826-13956D94FA74

Q37185756-5F889E86-5DC5-437E-B0D2-24CC3D3F69E9

Q37185756-6C4F02AD-0006-4736-849E-6BA5321C11B8

Q37185756-CDA7E2F1-67F0-4E94-A3DC-C84BFABB8C28

P2860

Q37185756-0F6D8A0C-0998-4944-BFE4-816D610B2D7A

Q37185756-153589D1-4C4C-4DAB-A5C3-1C479437B6D0

Q37185756-1D232314-F142-4352-9746-7C5ACFCCBFC5

Q37185756-262377D3-C38F-4848-A470-61598D80F1D0

Q37185756-3D90DB1F-0189-4890-8588-552C8DCFAA9C

Q37185756-4C9BE67D-47BE-409F-9516-8A82D1294C8D

Q37185756-5B21CCE5-2DCA-4C82-B8D4-299038F920E8

Q37185756-5BF54A21-C5FC-4D4D-97AA-F044A3D27241

Q37185756-797C18C0-F675-4A1D-98F1-049E5F71C884

Q37185756-7C950C3C-9140-4D66-8EEE-3519D9BCC0C7

P2888

Q37185756-D620B90D-6690-442C-B393-7724E4A6BA11

P304

Q37185756-63EAA8E7-2EA5-4F8D-85DF-BC592DAB1C2A

P31

Q37185756-64B8C0CD-4E38-4130-B4FF-D2C8FA5E89A4

P356

Q37185756-A85C0637-259A-4AAB-9815-7A0B1880C984

P407

Q37185756-0F2161D2-97D1-4EED-9EEB-390EB17DDAD4

P433

Q37185756-626FF5B2-12A0-46F3-A467-88023D99779D

P478

Q37185756-62EE269B-DB85-4B68-B46C-68F9994FB81C

P577

Q37185756-3DF11C99-C447-410E-A140-A2168D746198

P5875

Q37185756-DE0FDB21-E140-429E-90B8-856631A919E4

P698

Q37185756-F26E4BAC-5186-4FEA-8718-1B5E4147B2DF

P921

Q37185756-706C583C-2F84-43B3-A282-A384BF532DF9

P932

Q37185756-8A89695D-D1CF-476F-AF52-C866198978F1

P356

P1433

British Journal of Cancer

P1476

Interferon-β gene-modified hum ...... inhibiting AKT/FOXO3a pathway.

@en

P2093

B-L Lin

http://www.w3.org/2001/XMLSchema#string

C Xie

http://www.w3.org/2001/XMLSchema#string

D-Y Xie

http://www.w3.org/2001/XMLSchema#string

G-L Zhang

http://www.w3.org/2001/XMLSchema#string

L Peng

http://www.w3.org/2001/XMLSchema#string

P-P Wang

http://www.w3.org/2001/XMLSchema#string

Z-L Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors

FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal

Global cancer statistics, 2002

Smad transcription factors

Interferon-α/β and anti-fibroblast growth factor receptor 1 monoclonal antibody suppress hepatic cancer cells in vitro and in vivo

Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells

Dynamic FoxO transcription factors.

Many forks in the path: cycling with FoxO.

Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model.

Molecular mechanisms of hepatocellular carcinoma.

P2888

P304

1198-1205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2013.422

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

252325112

http://www.w3.org/2001/XMLSchema#string

P698

23887606

http://www.w3.org/2001/XMLSchema#string

P921

P932

3778282

http://www.w3.org/2001/XMLSchema#string